ReviewBritish journal of pharmacology2018

Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease.

Darren M O'Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.